Latest news with #Danone
Time of India
2 hours ago
- Business
- Time of India
Dannon parent sues Chobani over cold brew coffee slogan, packaging
The maker of Dannon yogurt sued rival Chobani on Tuesday for allegedly copying its "Bright & Mellow" slogan and yellow-and-black packaging for a competing line of ready-to-drink cold brew coffee. Danone said Chobani engaged in "knowing, calculated, and systematic" trademark infringement by using packaging for La Colombe-branded coffee that was "strikingly similar" to packaging for its own SToK coffee. The lawsuit is at least the third between Danone and Chobani in the last decade. In its complaint in Manhattan federal court, Danone said it began using "Bright & Mellow" in January 2021 to distinguish itself from Starbucks and then-independent La Colombe, which emphasized roast levels and coffee bean origins. It said that after buying La Colombe for $900 million in December 2023, Chobani substituted "Bright & Mellow" for that brand's "Bright & Flavorful" on coffee packaging, and now calls the product "light roast" instead of "medium roast." Danone said this inevitably causes consumer confusion , especially among hurried shoppers scanning shelves in their local Kroger, Target or Walmart. The changes will "cause severe and irreparable harm to Danone and the goodwill it has built up in the Bright & Mellow mark over the past four and a half years," Danone said. Chobani did not immediately respond to requests for comment. Danone is based in Paris. Its U.S. unit is based in White Plains, New York, while Chobani is based in upstate Norwich, New York. The lawsuit seeks an injunction to stop Chobani from selling products that could cause confusion, plus lost profits and triple damages. The case is Danone US LLC et al v Chobani LLC, U.S. District Court, Southern District of New York, No. 25-06217.
Reuters
4 hours ago
- Business
- Reuters
Danone shares shine after Q2 sales beat expectations thanks to strong China
PARIS, July 30 (Reuters) - Danone ( opens new tab shares rose as much as 7% on Wednesday after it delivered second-quarter sales that beat expectations, boosted by strong demand in China for infant milk formula and medical nutrition products. That largely outpaced weakness in the water segment in Latin America due to rainy and cold weather in Mexico, and coffee creamer sales still sluggish in a competitive U.S. market. The French consumer goods group, whose brands include Evian and Badoit water and Activia yoghurt, said second-quarter sales rose 4.1% on a like-for-like basis, beating expectations of a 3.8% increase in a company-provided analysts' consensus. Danone's recurring operating income for the first half of 2025 was 1.811 billion euros ($2.09 billion), with a margin of 13.2% of sales against 12.7% a year ago. The company reiterated that its full-year 2025 forecast was in line with its mid-term ambition of like-for-like sales growth of between 3% and 5%, with recurring operating income growing faster than sales. The first-half performance reflected "the strength and resilience of our health-focused portfolio," said CEO Antoine de Saint-Affrique. "The name of the game for us is performing consistently while transforming and fixing what needs to be fixed," he added, citing the plant-based business and coffee creamers in the United States. By 0807 GMT Danone shares were up 6.6% at 70.72 euros. "This is a reassuring update," Jefferies analysts said in a note. "The notably strong beat in China Nutrition will quash worries that the category competitiveness is less favorable. It suggests that Danone continues to be a winner in this region, while others struggle." China, North Asia and Oceania had another stellar quarter, with sales up 12.4% like-for-like. Specialized Nutrition recorded double-digit growth, driven by strong growth both in Infant Milk Formula and Medical Nutrition. In North America sales rose 2.3% in the quarter, driven by double-digit growth in protein products such as the Oikos brand Greek yoghurt, while coffee creamers were progressively recovering following supply chain issues in the first quarter. Danone has been using some of its cash for acquisitions to boost its focus on health and science, and build resilience to a volatile environment. It recently bought the Akkermansia Company, a Belgian biotics firm, and took a majority stake in Kate Farms, a U.S. plant-based maker of organic formula and shakes. "We don't stop there," Saint-Affrique told analysts. "There are more acquisitions to come. We are working on a number of things." ($1=0.8654 euros)
Bloomberg
6 hours ago
- Business
- Bloomberg
Stock Movers: Adidas, Kering, Danone
On this episode of Stock Movers: - Adidas shares plunge as much as 8.6%, the most in over three months after the footwear giant reported weaker than expected revenue growth which offset a margin beat. The lack of guidance upgrade is driven by increased tariff uncertainty and is a further disappointment. - Kering shares rose 2.7% after the luxury-goods maker reported better-than-expected operating profit but plunging sales at Gucci which is undergoing a second design revamp in three years. - Danone shares gained the most in three years after sales beat expectations as the French consumer goods company saw volumes rise in most of its categories, including high-protein products.
Reuters
8 hours ago
- Business
- Reuters
Strong Chinese demand helps Danone second-quarter sales beat expectations
PARIS, July 30 (Reuters) - Danone ( opens new tab on Wednesday reported second-quarter sales that beat expectations, boosted by strong demand in China for infant milk formula and medical nutrition products. This largely outpaced weakness in the water segment in Latin America due to rainy and cold weather in Mexico, and still sluggish coffee creamer sales in a competitive U.S. market. The French consumer goods group, whose brands include Evian and Badoit water and Activia yoghurt, said second-quarter sales rose 4.1% on a like-for-like basis, compared with expectations of 3.8% increase in a company-provided analysts' consensus. Danone's recurring operating income for the first half of 2025 was 1.811 billion euros ($2.09 billion), with a margin of 13.2% of sales against 12.7% a year ago. The company reiterated that its full-year 2025 forecast was in line with its mid-term ambition of like-for-like sales growth of between 3% and 5%, with recurring operating income growing faster than sales. The first half performance reflected "the strength and resilience of our health-focused portfolio," said CEO Antoine de Saint-Affrique, adding that Danone was focused on "the consistent execution of our consumer-centric and science-based strategy and the delivery of our mid-term guidance." Danone, which ended last year with record cash of 3 billion euros, has been using some of it for acquisitions to boost its focus on health and science, and build resilience to a volatile environment marked by U.S. tariff uncertainty and weak consumer sentiment. The group recently bought The Akkermansia Company, a Belgian biotics company, as well as a majority stake in Kate Farms, a U.S. plant-based organic formula and shakes maker. Danone, like rivals Unilever (ULVR.L), opens new tab and Nestle (NESN.S), opens new tab, has slowed price hikes after three years of steep increases following the COVID-19 pandemic to win back shoppers who had turned to cheaper brands amid elevated inflation. In the second quarter alone, volumes contributed 3.2% to revenue growth and prices 1%. ($1 = 0.8654 euros)
Reuters
9 hours ago
- Business
- Reuters
Strong Chinese demand help Danone Q2 sales beat expectations
PARIS, July 30 (Reuters) - Danone ( opens new tab on Wednesday reported second-quarter sales that beat expectations, boosted by strong demand in China for infant milk formula and medical nutrition products, offsetting weakness in coffee creamers amid a competitive U.S. market. The French consumer goods group, whose brands include Evian and Badoit water and Activia yoghurt, said second-quarter sales rose 4.1% on a like-for-like basis, compared with expectations of 3.8% in a company-provided analysts' consensus. Danone's recurring operating income for the first half of 2025 was 1.811 billion euros ($2.09 billion), with a margin of 13.2% of sales against 12.7% a year ago. The company reiterated its full-year 2025 forecast was in line with its mid-term ambition of like-for-like sales growth of between 3% and 5%, with recurring operating income growing faster than sales. ($1 = 0.8654 euros)
